All About Multiple Sclerosis

More MS news articles for June 2003

Demyelination does not necessarily deplete oligodendrocyte progenitors

http://www.bostoncure.org:8080/article.pl?sid=03/06/04/1137239&mode=nested

Wednesday, June 4, 2003
Hollie
Boston Cure Project for Multiple Sclerosis

There are many hypotheses to explain why lesions fail to remyelinate fully in MS. The depletion hypothesis states that repeated episodes of demyelination and remyelination in an area eventually uses up that area's supply of oligodendrocyte progenitor cells (OPCs). A new study argues against that hypothesis using a technique that induces targeted demyelinating lesions in the brain of an animal.

In these experiments, researchers injected a gliotoxin, ethidium bromide, into a specific area of the brain of rats. Up to three injections were made in the same area with a period of several weeks in between injections to allow for complete remyelination. Examination of the brain tissue showed that concentrations of OPCs were similar to that in normal white matter, even after repeated episodes of demyelination. In addition, repeated episodes of demyelination did not appear to impair remyelination.

While this study does not explain what actually causes failure of remyelination in MS, it does demonstrate that repeated demyelination does not automatically cause a progressive depletion of OPCs (at least not in rats and not after three targeted lesions -- perhaps a higher number of episodes would have produced a different outcome). Rather, these findings tend to support the hypothesis that failure to remyelinate is due to the presence of inhibitory factors in an MS lesion, and/or the absence of critical pro-remyelinating factors.
 

Copyright © 2003, Boston Cure Project for Multiple Sclerosis